ReNeuron Group PLC (LON:RENE)

ReNeuron Group PLC (LON:RENE)

Share Price
238.00 p
-6 (-2.46 %)
Market Cap
£75.69 m
Proactive Investors - Run By Investors For Investors

ReNeuron Group PLC

ReNeuron is a leading, clinical-stage stem cell business.  Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.

Market: LSE:RENE
52-week High/Low: 342.00p / 29.50p
Sector: Pharma & Biotech
Market Cap: £75.69 m
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of ReNeuron Group PLC

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use